Private Equity

The miner posted a $2.9B free cash flow and a record $1.8B dividend payout, fueled by high gold prices and strategic growth in its 2025 earnings.

The junior explorer secures crucial funding from a renowned investor, fueling its nickel-copper ambitions in Canada's critical mineral heartland.

Ghana ratifies a major oil deal with Kosmos Energy until 2040, promising $2B in investment but raising questions about long-term financial and green goals.

Global distributor IMCD deepens its food and nutrition footprint with the strategic acquisition of Willows Ingredients, targeting high-growth niche markets.

A drop in 2025 revenue hides Orano's strong operational health, reduced debt, and major strategic wins, including a key US uranium enrichment project.

A new all-inclusive package at Haneda Airport offers kimonos and fine dining, transforming the layover into a curated cultural journey for elite travelers.

Warrior Met Coal touts major ESG progress in its new report, but a simultaneous billion-dollar mine expansion in Alabama raises complex questions.

With its 2025 results fresh, Green Plains will outline its strategy for high-value biorefining and renewable fuels at a key BofA conference.

The founders of It's a 10 Haircare are back with Cloud, a new brand taking over shelves at CVS, Amazon, and more with its under-$10, salon-quality promise.

A new investment aims to bolster NYC's grid with battery storage, but developers face a charged debate between climate goals and community safety fears.

Railcar leasing giant reports stellar 2025 earnings after its largest acquisition ever, rewarding investors with a dividend hike and new buyback plan.

A trio of franchise veterans has acquired WonderPlay Brands, aiming to rapidly scale its Kidcreate Studio art enrichment concept across the United States.

A new cohort of Black leaders and allies begins a world-class program aimed at breaking barriers to the C-suite and reshaping corporate America.

Cybersecurity leader KnowBe4 appoints Yuneeb Khan as CFO, signaling a strategic focus on scaling its AI-driven human risk management platform.

A national provider's acquisition of a New Mexico leader promises to blend technology, research, and capital to reshape autism therapy in underserved regions.

INmune Bio will present key Phase III results for CORDStrom, a systemic cell therapy for the devastating rare skin disease RDEB. Will it be a breakthrough?

In a major deal with Avolon, ACG expands its fleet with new-tech jets, signaling an aggressive growth strategy in a high-demand aircraft leasing market.

As Milwaukee faces a housing crisis, a $38M project will preserve 150 affordable homes, adding green upgrades without displacing a single resident.

An independent candidate proposes a $50,000 graduate dividend, funded by redirecting billions in offshore pension wealth to tackle youth disenfranchisement.

Facing shrinking margins and investor demands, healthcare leaders are ditching AI experiments for automation that delivers immediate financial lift and audit-ready results.